Dave Mead, Director of Business Devlopment, will be representing Isogenica at the forthcoming the Antibody Engineering & Therapeutics 2019 meeting.

 

Contact This email address is being protected from spambots. You need JavaScript enabled to view it. for further information or for an opportunity to meet and learn the latest developments at Isogenica.

 

Download our infographic VHH as biotherapeutics 

 

https://lifesciences.knect365.com/antibody-engineering-europe/